- Report
- November 2023
- 182 Pages
Global
From €4701EUR$4,900USD£4,065GBP
- Report
- July 2023
- 220 Pages
Global
€4409EUR$4,595USD£3,812GBP
- Report
- May 2024
- 187 Pages
From €3237EUR$3,374USD£2,799GBP
€3597EUR$3,749USD£3,111GBP
- Report
- March 2024
- 266 Pages
From €3454EUR$3,600USD£2,987GBP
- Drug Pipelines
- June 2020
- 127 Pages
Global
From €1919EUR$2,000USD£1,659GBP
- Report
- November 2023
- 25 Pages
India
From €825EUR$921USD£738GBP
- Report
- January 2024
- 91 Pages
Global
From €3500EUR$3,908USD£3,132GBP
- Report
- November 2022
- 106 Pages
Global
From €1919EUR$2,000USD£1,659GBP
- Report
- May 2023
- 160 Pages
Global
From €5756EUR$5,999USD£4,977GBP
The Nasal Congestion market is a subset of the Cough and Cold Drugs market, which includes medications used to treat symptoms of the common cold, such as nasal congestion, sore throat, and cough. Nasal congestion is a common symptom of the common cold, and is caused by inflammation of the nasal passages. Nasal congestion medications are typically decongestants, which reduce inflammation and open the nasal passages. These medications are available in a variety of forms, including tablets, capsules, liquids, and nasal sprays.
Nasal congestion medications are widely available over-the-counter, and are often used in combination with other medications to treat the common cold. They are also used to treat allergies, sinus infections, and other respiratory conditions.
Some companies in the Nasal Congestion market include GlaxoSmithKline, Pfizer, Novartis, Sanofi, and Merck. Show Less Read more